Advertisement
U.S. Markets open in 2 hrs 7 mins
S&P Futures
5,758.50 +20.00 (+0.35%) Dow Futures
42,086.00 +139.00 (+0.33%) Nasdaq Futures
20,103.50 +81.75 (+0.41%) Russell 2000 Futures
2,209.70 +1.10 (+0.05%) Crude Oil
70.70 +1.44 (+2.08%) Gold
2,761.10 +11.80 (+0.43%)
Health & Lifestyle
BusinessReutersAbbott shares rise after securing first win in premature infant formula trial
A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's severe intestinal disease, marking the first victory for the companies after large losses in two previous trials. The lawsuit was one of about 1,000 similar cases pending nationwide over allegations the companies failed to warn that their specialized formulas used by newborn intensive care units in hospitals could cause necrotizing enterocolitis (NEC). NEC almost exclusively affects premature infants and has an estimated mortality rate of more than 20%.
U.S.USA TODAY2 dead, 6 injured in Halloween mass shooting in downtown Orlando; suspect detained: Police
A shooting in downtown Orlando on Halloween night has left two people dead and at least six others injured, according to police.
Advertisement
Advertisement